Therefore, based on the distinctive status of MYD88 variants, we provide a potential new method of molecular genetic analysis to address the difficulties of using the RMH scoring system for the differential diagnosis of atypical CLL/SLL and MCL. This evidence concerns the gene MYD88 and mantle cell lymphoma.